Experiences with

Appendix cancer

I am in various FB groups for PSEUDOMYXOMA Peritonei but was wondering if g in there is much activity or questions in this forum for PMP/Appendix Cancer

It is feeling like I have both Ovarian and Appendix cancer. No idea if it is two primaries or metastatic. Will only speak with my gyn oncologist tomorrow for the first time. So terrified.

A pelvic MRI was booked for the following month - I have yearly abdominal MRI surveillance due to Appendix Cancer in 2021. MRI report came back and it states the following - “Both ovaries demonstrate polycystic morphology.

I had CRS and HIPEC at Basingstoke Peritoneal Malignancy Unit when it was initially thought that I had Pseudomyxoma Peritoni which comes from the appendix. Surgery removed all visible cancer but so I had a CC0 score and PCI 13. However histology came back as MOC of GI type.

I was initially diagnosed with prostate cancer un 2021 and treated with 23 radiation treatments and radioactive beads. In April of 2024 my Psa started to rise significantly and subsequent imaging showed I had stage 4 cancer that had spread to my lymph nodes. I was put on leuprolide inJune of 2024 and

N of 3. All 3 men who started pBAT during HSPC are still HSPC. BAT might help prevent the emergence of CRPC by 1. Inducing AR Cycling Instead of Persistent Upregulation: In hormone-sensitive prostate cancer (HSPC), BAT creates a fluctuating environment where AR levels rise during ADT phases and

I was a Glason 8 with PSA 5.2 and had surgery to remove my prostate in 2018. My PSA has always been <0.02 since surgery and for past 2 years I’ve gotten my PSA tested annually. Last week I had my annual PSA test and my PSA was 0.03. Always get tested at same lab on same type of machine. Should

I will be on on my third cycle next Monday. Bloodtest was very good, but PSA is still rising. From 4.29 from 2 months ago, now 5.50. Is it to early to expect if it's working? I'm very worried, even if I don't have any symptoms from my stage 4 mcrPC.

I am writing this to see if anyone has followed a similar path and can offer impressions of side effects for Erleada vs Abiriterone. Diagnosed stage 4 July 2022. Gleason 3+4. Started Abiraterone/Pred, Lupron, Zometa in September, so have been on it 2.5yrs. The lowest my PSA got was 0.14 in January

Just curious if there’s any indication if this new drug will succeed Abiraterone and Xtandi? Thanks, Elisa

I thought that Rad-140/150 was safer than Ostarine or Ligandrol. The majority of the evidence now points me to Ostarine being the safest. Risk Comparison Table Parameter Ostarine Ligandrol RAD-140 Winner AR Agonism Partial Full Full Ostarine Prostate AR Activation Low Moderate High Ostarine Hepatotoxicity

I’m 48 and was diagnosed last year with advanced metastatic prostate cancer, affecting my lymph nodes, pelvic bones, and ribs. I finished chemo with Docetaxel in December. Given my age, I’m aiming for an aggressive treatment approach and am currently exploring radiation to the prostate and pelvic bones

Please check out our recent workshop featuring patients who have received treatments for different liver conditions! They will share their stories, followed by a Q&A session. This event is perfect for liver cancer patients, caregivers, providers, or anyone interested in learning more about liver health

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-expands-pluvictos-metastatic-castration-resistant-prostate-cancer-indication They based their "expanded-use" approval on the PSMAfore trial. In addition to mCRPC, men had to: • have tried one ARPi (Zytiga, Xtandi, Erleada or Nubeqa

recently started both Orgo and Xtandi for stage 4 Had previous HD brachy and EBRT of prostate which went well had cat and bone scans after that showed nothing except 4 bone mets 2 in spine and 2 in lower spin and hip These probably escaped prior to my above treatments as the treated area looks

Good evening fellow warriors and members of this f’n club none of us signed up for. I started this journey 6/2012 with Gleason 9 (5+4) and a RP, Surgical pathology showed seminal vesicle invasion, 2 positive pelvic nodes and a good luck from my surgeon. Reoccurrence 2013 brought on pelvic EBRT and short

Hrd negative test so what exactly is next if no Parp inhibitors are available to me. Early stages of monitoring with weekly blood tests and going to see the surgeon for a checkup in a couple of months. Worried about return of the ovarian cancer.

In the LNCaP-abl model, prolonged androgen deprivation across approximately 87 cell culture passages (roughly 8–12 months in vitro) drives prostate cancer cells to adapt to low-androgen conditions. This adaptation includes: • AR Overexpression: A roughly 4-fold increase in androgen receptor (AR) protein

My husband was newly diagnosed with stage 4 prostate cancer Gleason 9,his psa is 58 now and he will start cemo on Thursday he is 51 years old What is the best way to tell our children, I don't want them to live the shock I'm living Thanks

Hi all, This is my first post here. My 66 year old father was diagnosed with metastatic PCa in April 2024. Initial PSA was 35.6, Gleason 5+4. A month later, PSMA-PET showed widespread mets in the tissues surrounding his prostate, including bones and lymph nodes. He did [i]not[/i] have mets in his head